|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/445 | (2006.01) |
| A61P 13/12 | (2006.01) |
| (11) | Number of the document | 4062916 |
| (13) | Kind of document | T |
| (96) | European patent application number | 22165669.7 |
| Date of filing the European patent application | 2018-05-30 | |
| (97) | Date of publication of the European application | 2022-09-28 |
| (45) | Date of publication and mention of the grant of the patent | 2024-10-09 |
| (46) | Date of publication of the claims translation | 2025-01-10 |
| (30) | Number | Date | Country code |
| 201762512458 P | 2017-05-30 | US | |
| 201862626953 P | 2018-02-06 | US |
| (72) |
CASTELLI, Jeff , US
|
| (73) |
Amicus Therapeutics, Inc. ,
3675 Market Street, Philadelphia, PA 19104,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Tam tikras mutacijas turinčių Fabri pacientų gydymas |
| TREATING FABRY PATIENTS HAVING CERTAIN MUTATIONS |
| Payment date | Validity (years) | Amount | |
| 2025-04-24 | 8 | 185.00 EUR |
| 2026-05-30 |